Depression in myasthenia gravis: a heterogeneous and intriguing entity

Area of Science:

• Neurology
• Psychiatry

Background:

• Depressive symptoms are frequent in myasthenia gravis (MG), potentially causing misdiagnosis.
• Clinical factors and distinct depression phenotypes in MG are understudied, especially their relation to fatigue.
• Understanding depression in MG is crucial for accurate diagnosis and treatment.

Purpose of the Study:

• To investigate the clinical determinants of depressive symptoms in myasthenia gravis.
• To examine the overlap between depression and fatigue in MG patients.
• To identify distinct depression phenotypes within the MG population.

Main Methods:

• 68 consecutive myasthenia gravis patients were assessed for depression using the Beck Depression Inventory (BDI), distinguishing cognitive-affective and somatic symptoms.
• Data collected included age at onset, education, marital status, work ability, sleepiness, fatigue, and treatment modalities.
• Disease severity was classified using the Myasthenia Gravis Foundation of America (MGFA) scale.

Main Results:

• The prevalence of moderate-to-severe depression was 20.5%.
• Depression and fatigue significantly overlapped (54.4%), but only fatigue correlated with disease severity.
• Thymectomy was linked to lower depression scores, while younger age and female sex were associated with specific depression subtypes.

Conclusions:

• Depression and fatigue are highly prevalent and overlapping comorbidities in myasthenia gravis.
• Fatigue, unlike depression, escalates with disease severity; depression is milder in thymectomized patients.
• Distinct depression phenotypes exist in MG, correlating differently with clinical features, highlighting the utility of BDI subscales.